HomeSearchHepatoma Research

Hepatoma Research

OAE Publishing Inc. · United States · Est. 2015

ISSN2454-2520
SJR Q3WOS ESCIScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3 · Scopus CiteScore 3.5. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q3
SJR · Scopus
Top 75% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.455
H-Indexi
25
CiteScorei
3.5
SNIPi
0.226
Total Worksi
590
Total Citationsi
3,812
2yr Mean Citednessi
1.67
Open Impact Factor alternative

Aims & Scope

Hepatoma Research is an international, open-access journal dedicated to the rapid publication of significant findings in the field of hepatoma (liver cancer). It covers a wide range of topics including hepatocellular carcinoma (HCC), liver cancer, liver tumors, hepatoblastoma, cholangiocarcinoma, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatitis B, hepatitis C, immunotherapy, systemic treatment, liver transplantation, liver resection, surgical management, surveillance, epidemiology, molecular mechanisms, tumor microenvironment, biomarkers, and stem cell research.

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published2015
Annual Volume~ 45 articles / year
StatusActive (last: 2026)
Total Publications590
OA Since2014
Visit Journal Website

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
📦 Long-term Preservation
Portico

Think.Check.Submit Compliance

7/11 · 64%
Do you know the journal / publisher?
OAE Publishing Inc.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2454-2520
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
Portico
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
44
303
2019
85
615
2020
78
525
2021
41
278
2022
53
147
2023
53
141
2024
29
57
2025
51
12
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HepatologyQ3
OncologyQ3

Subject Classification

Web of Science Categories

Gastroenterology & HepatologyOncology

Scopus Categories

OncologyHepatology

Research Topics (OpenAlex)

Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisHepatitis C virus researchCholangiocarcinoma and Gallbladder Cancer StudiesHepatitis B Virus StudiesLiver Disease and TransplantationLiver physiology and pathologyOrgan Transplantation Techniques and OutcomesCancer, Hypoxia, and MetabolismCancer Mechanisms and Therapy

Frequently asked questions about Hepatoma Research

Is Hepatoma Research a predatory journal?

PubScope has no integrity flags on record for Hepatoma Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Hepatoma Research?

Hepatoma Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 3.5.

Is Hepatoma Research indexed in Scopus and Web of Science?

Hepatoma Research is indexed in Web of Science, Scopus.

What is the aims and scope of Hepatoma Research?

Hepatoma Research is an international, open-access journal dedicated to the rapid publication of significant findings in the field of hepatoma (liver cancer). It covers a wide range of topics including hepatocellular carcinoma (HCC), liver cancer, liver tumors, hepatoblastoma, cholangiocarcinoma, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatitis B, hepatitis C, immunotherapy, systemic treatment, liver transplantation, liver resection, surgical management, surveillance, epidemiology, molecular mechanisms, tumor microenvironment, biomarkers, and stem cell r

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref